2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

What Drivers Are Shaping the Growth and Development of thePulmonary Embolism Market?

The escalating instances of blood clots are predicted to stimulate the expansion of the pulmonary embolism market. A blood clot, or thrombus, is characterized as a semi-solid or gel-like mass that develops within a blood vessel. These clots enhance the threat of pulmonary embolism by hindering the flow of blood to the lungs. A blood clot usually results in blockage, predominantly in the deep veins of the legs, thereby escalating the risk of pulmonary embolism. For example, in April 2022, Gavi, the Vaccine Alliance, an international organization established to broaden access to new and underutilized vaccines for children, cited in an article that scientists identified a 33-fold surge in the probability of lethal lung clots and a five-fold uptick in the risk of deep vein thrombosis within 30 days of exposure to COVID-19. Therefore, the rising instances of blood clots are promoting the expansion of the pulmonary embolism market. The Pulmonary Embolism Market Driver has identified that the escalating occurrence of cancer is fostering the growth of the pulmonary embolism market. Cancer comprises a set of diseases marked by unregulated and abnormal cell growth within the body. An upsurge in the prevalence of cancer elevates the threat of blood clots, including pulmonary embolism, among cancer patients. This results in an increased demand for diagnosis and treatments, inclusive of specialized medications. For example, in January 2024, the American Cancer Society, a United States-based nonprofit organization advocating for cancer, reported that the number of cancer cases had risen to 2,001,140 compared to 1,958,310 in 2023, indicating a growth of 2.19%. Hence, the escalating incidence of cancer is fostering the growth of the pulmonary embolism market.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13026&type=smp

#What is the Anticipated CAGR of thePulmonary Embolism Market, and What Factors Will Drive It?

The market size for pulmonary embolism has seen considerable growth in the recent past. It’s projected to increase from $2.03 billion in 2024 to $2.27 billion in 2025, boasting a compound annual growth rate (CAGR) of 11.9%. The significant growth during the historic period is credited to the rise of anticoagulant therapies, research progress and clinical trials, increased understanding of pulmonary embolism, and vte prophylaxis.

The expected expansion rate for the pulmonary embolism market over the next few years is projected to be swift, with its worth estimated to reach $3.63 billion by 2029, growing at a compound annual growth rate (CAGR) of 12.5%. The motivation behind this significant growth over the forecast period can be attributed to factors such as targeted therapies, the use of telemedicine and remote monitoring, initiatives promoting health equity, and international health campaigns. Additionally, key trends expected to emerge during the forecast window encompass the application of artificial intelligence in diagnostic procedures, the advent of novel anticoagulants, the establishment of pulmonary embolism response teams, and the implementation of patient-centered care models.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13026

Which Cutting-Edge Market Trends Are Expected to Drive thePulmonary Embolism Market’s Growth?

The pulmonary embolism market is dominated by leading corporations that are concentrating on the creation of groundbreaking products like the Triever16 Curve catheter and the RevCore thrombectomy catheter to gain a competitive edge. Inari Medical Inc., a medical device company based in the United States, took initiative in June 2023 by launching the Triever16 Curve catheter and the RevCore thrombectomy catheter. The Triever16 Curve catheter, a fresh concept, is built for peripheral thrombectomy and pulmonary embolism operations. The catheter is highly trackable, featuring a pre-shaped curve for concentrated aspiration and a distinctive design that makes it easy to use with larger and more potent 20F or 24F catheters. The RevCore thrombectomy catheter is tailored to treat venous in-stent thrombosis, boasting a mechanical thrombectomy device that employs a nitinol basket to trap and eradicate blood clots. Furthermore, these catheters enhance the safety and efficacy of pulmonary embolism procedures.

What Are the Leading Market Players Impacting thePulmonary Embolism Market’s Growth Trend?

Major companies operating in the pulmonary embolism market are Pfizer Inc., Johnson and Johnson Private Limited, F. Hoffmann-La Roche Ltd., Merck And Co.Inc., Novartis AG, Bayer AG, Sanofi S.A., Bristol Myers Squibb Company, GSK PLC, Abbott Laboratories, AstraZeneca PLC, Medtronic PLC, Eli Lilly and Company, Gilead Sciences Inc., Baxter International Inc., Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Mylan N.V., Daiichi Sankyo Co. Ltd., Boehringer Ingelheim International GmbH, Mitsubishi Tanabe Pharma Corporation, Genentech Inc., Hikma Pharmaceuticals PLC, Aspen Pharmacare Holdings Limited, Nippon Shinyaku Co. Ltd., Penumbra Inc., Fresenius Kabi AG, Inari Medical Inc., AngioDynamics Inc., Otsuka Pharmaceutical Co. Ltd.

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/pulmonary-embolism-global-market-report

How Are the Key Segments of the Pulmonary Embolism Market Driving Opportunities and Innovations?

The pulmonary embolism market covered in this report is segmented –

1) By Treatment: Medications, Mechanical Devices, Other Treatments

2) By Diagnosis: Chest X-Ray, Electrocardiogram (ECG), Magnetic Resonance Imaging (MRI), Computed Tomography Scan, Pulmonary Angiography, Venography, Venous Ultrasound, D-Dimer Test, Other Diagnosis

3) By Symptoms: Shortness Of Breath, Chest Pain, Cough, Irregular Heartbeat, Dizziness, Fever, Cyanosis, Other Symptoms

4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channels

5) By End-User: Hospitals, Specialty Clinics, Homecare, Other End-Users

Subsegments:

1) By Medications: Anticoagulants, Thrombolytics

2) By Mechanical Devices: Inferior Vena Cava (IVC) Filters, Catheter-Assisted Thrombectomy

3) By Other Treatments: Surgical Embolectomy, Supportive Care

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=13026&type=smp

What Regions Are At the Forefront of #What Drivers Are Shaping the Growth and Development of thePulmonary Embolism Market?# Market Expansion?

North America was the largest region in the pulmonary embolism market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in pulmonary embolism market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Browse Through More Reports Similar to the Global Pulmonary Embolism Market 2025, By The Business Research Company:

Cardiac Marker Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cardiac-marker-global-market-report

Cardiac Assist Devices And Equipment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cardiac-assist-devices-and-equipment-global-market-report

Cardiac Pacemakers Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cardiac-pacemakers-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: